US · Healthcare

Turn Therapeutics Inc. Common Stock (TTRX)

Biotechnology

Turn Therapeutics Inc. Common Stock (TTRX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for TTRX

P/E ratio
18.00

Turn Therapeutics Inc. Common Stock (TTRX) — FAQ

What is TTRX's P/E ratio?

The price-to-earnings (P/E) ratio for Turn Therapeutics Inc. Common Stock (TTRX) is 18.00 (data as of 2026-03-25).

Does Turn Therapeutics Inc. Common Stock pay a dividend?

Dividend yield is not available in the current snapshot for Turn Therapeutics Inc. Common Stock (TTRX). Check the MyAverix Finance app for the latest dividend data.

What sector is Turn Therapeutics Inc. Common Stock in?

Turn Therapeutics Inc. Common Stock (TTRX) is classified in the Healthcare sector (Biotechnology industry).

What exchange is TTRX listed on?

TTRX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play